{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:37:58Z","timestamp":1790800678085,"version":"4.1.0"},"reference-count":43,"publisher":"BMJ","funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEPAMAB GAN 305600"],"award-info":[{"award-number":["HEPAMAB GAN 305600"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000032","name":"Institute of Infection and Immunity","doi-asserted-by":"publisher","award":["201411MFE-338606-245517"],"award-info":[{"award-number":["201411MFE-338606-245517"]}],"id":[{"id":"10.13039\/501100000032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2008-AdG-HEPCENT"],"award-info":[{"award-number":["ERC-2008-AdG-HEPCENT"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2014-AdG-HEPCIR"],"award-info":[{"award-number":["ERC-2014-AdG-HEPCIR"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["H2020 HEPCAR"],"award-info":[{"award-number":["H2020 HEPCAR"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les Hepatites Virales","doi-asserted-by":"publisher","award":["2012\/318"],"award-info":[{"award-number":["2012\/318"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les Hepatites Virales","doi-asserted-by":"publisher","award":["2013\/108"],"award-info":[{"award-number":["2013\/108"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"DOI":"10.1136\/gutjnl-2016-312577","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:26:28Z","timestamp":1490919988000},"page":"gutjnl-2016-312577","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape"],"prefix":"10.1136","author":[{"given":"Che C","family":"Colpitts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv G","family":"Tawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Thumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heydmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Robinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5635-7437","authenticated-orcid":false,"given":"Patrick","family":"Pessaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam B","family":"Zeisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,3,30]]},"reference":[{"key":"key-10.1136\/gutjnl-2016-312577-1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.09.011","article-title":"The importance of resistance to direct antiviral drugs in HCV infection in clinical practice","volume":"64","author":"Sarrazin","year":"2016","journal-title":"J Hepatol"},{"key":"key-10.1136\/gutjnl-2016-312577-2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"key-10.1136\/gutjnl-2016-312577-3","article-title":"Detection of occult hepatitis C virus infection in patients who achieved a sustained virologic response to direct-acting antiviral agents for recurrent infection after liver transplantation","author":"Elmasry","year":"2016","journal-title":"Gastroenterology"},{"key":"key-10.1136\/gutjnl-2016-312577-4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMra1213651","article-title":"Current and future therapies for hepatitis C virus infection","volume":"368","author":"Liang","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.1136\/gutjnl-2016-312577-5","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/gutjnl-2015-310421","article-title":"Hepatitis C virus treatment in the real world: optimising treatment and access to therapies","volume":"64","author":"Zoulim","year":"2015","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2016-312577-6","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and Velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.1136\/gutjnl-2016-312577-7","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMp1400986","article-title":"Curing chronic hepatitis C--the arc of a medical triumph","volume":"370","author":"Chung","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.1136\/gutjnl-2016-312577-8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1473-3099(16)00120-1","article-title":"New perspectives for preventing hepatitis C virus liver graft infection","volume":"16","author":"Felmlee","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.1136\/gutjnl-2016-312577-9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2014.09.023","article-title":"Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study","volume":"148","author":"Curry","year":"2015","journal-title":"Gastroenterology"},{"key":"key-10.1136\/gutjnl-2016-312577-10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.healun.2015.10.012","article-title":"Impact of donor and recipient hepatitis C status in lung transplantation","volume":"35","author":"Englum","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"key-10.1136\/gutjnl-2016-312577-11","unstructured":"\u201cOrgan Procurement and Transplant Data\u201d 2016; Retrieved October 1, 2016. http:\/\/optn.transplant.hrsa.gov\/data\/"},{"key":"key-10.1136\/gutjnl-2016-312577-12","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"key-10.1136\/gutjnl-2016-312577-13","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"key-10.1136\/gutjnl-2016-312577-14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"key-10.1136\/gutjnl-2016-312577-15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"key-10.1136\/gutjnl-2016-312577-16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat Med"},{"key":"key-10.1136\/gutjnl-2016-312577-17","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1073\/pnas.1602701113","article-title":"Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/gutjnl-2016-312577-18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.22547","article-title":"Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo","volume":"48","author":"Meuleman","year":"2008","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2016-312577-19","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/hep.27196","article-title":"Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents","volume":"60","author":"Vercauteren","year":"2014","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2016-312577-20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/j.gastro.2010.05.073","article-title":"Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes","volume":"139","author":"Fofana","year":"2010","journal-title":"Gastroenterology"},{"key":"key-10.1136\/gutjnl-2016-312577-21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt.3179","article-title":"Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody","volume":"33","author":"Mailly","year":"2015","journal-title":"Nat Biotechnol"},{"key":"key-10.1136\/gutjnl-2016-312577-22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1099\/jgv.0.000330","article-title":"Novel human anti-Claudin 1 monoclonal antibodies inhibit HCV infection and may synergize with anti-SRB1 mAb","volume":"97","author":"Paciello","year":"2015","journal-title":"J Gen Virol"},{"key":"key-10.1136\/gutjnl-2016-312577-23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1124\/jpet.114.217653","article-title":"Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus","volume":"353","author":"Yamashita","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.1136\/gutjnl-2016-312577-24","doi-asserted-by":"crossref","first-page":"282ra49","DOI":"10.1126\/scitranslmed.3010286","article-title":"Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection","volume":"7","author":"He","year":"2015","journal-title":"Sci Transl Med"},{"key":"key-10.1136\/gutjnl-2016-312577-25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/gutjnl-2013-306155","article-title":"Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C","volume":"64","author":"Xiao","year":"2015","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2016-312577-26","doi-asserted-by":"crossref","first-page":"e1004128","DOI":"10.1371\/journal.ppat.1004128","article-title":"Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents","volume":"10","author":"Xiao","year":"2014","journal-title":"PLoS Pathog"},{"key":"key-10.1136\/gutjnl-2016-312577-27","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1128\/JVI.01457-07","article-title":"Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus","volume":"81","author":"Zheng","year":"2007","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2016-312577-28","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1128\/JVI.01977-07","article-title":"The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus","volume":"82","author":"Meertens","year":"2008","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2016-312577-29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.26567","article-title":"Isolate-dependent use of claudins for cell entry by hepatitis C virus","volume":"59","author":"Haid","year":"2014","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2016-312577-30","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1128\/JVI.01691-13","article-title":"Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies","volume":"87","author":"Fofana","year":"2013","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2016-312577-31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations","volume":"51","author":"Krieger","year":"2010","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2016-312577-32","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.4049\/jimmunol.147.5.1709","article-title":"Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites","volume":"147","author":"Kabat","year":"1991","journal-title":"J Immunol"},{"key":"key-10.1136\/gutjnl-2016-312577-33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/321522a0","article-title":"Replacing the complementarity-determining regions in a human antibody with those from a mouse","volume":"321","author":"Jones","year":"1986","journal-title":"Nature"},{"key":"key-10.1136\/gutjnl-2016-312577-34","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.2451287","article-title":"Reshaping human antibodies: grafting an antilysozyme activity","volume":"239","author":"Verhoeyen","year":"1988","journal-title":"Science"},{"key":"key-10.1136\/gutjnl-2016-312577-35","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1128\/JVI.00246-09","article-title":"Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells","volume":"83","author":"Mee","year":"2009","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2016-312577-36","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/gutjnl-2016-312577-37","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation","volume":"207","author":"Fafi-Kremer","year":"2010","journal-title":"J Exp Med"},{"key":"key-10.1136\/gutjnl-2016-312577-38","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1128\/JVI.02460-05","article-title":"Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses","volume":"80","author":"Koutsoudakis","year":"2006","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2016-312577-39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1099\/vir.0.006700-0","article-title":"CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells","volume":"90","author":"Witteveldt","year":"2009","journal-title":"J Gen Virol"},{"key":"key-10.1136\/gutjnl-2016-312577-40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug-drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antiviral Res"},{"key":"key-10.1136\/gutjnl-2016-312577-41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"key-10.1136\/gutjnl-2016-312577-42","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/TP.0000000000000479","article-title":"Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts","volume":"99","author":"Scalea","year":"2015","journal-title":"Transplantation"},{"key":"key-10.1136\/gutjnl-2016-312577-43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C-positive kidneys","volume":"373","author":"Reese","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2016-312577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T23:02:01Z","timestamp":1692745321000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2016-312577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,30]]},"references-count":43,"alternative-id":["10.1136\/gutjnl-2016-312577"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2016-312577","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,30]]}}}